article_metadata: Evelien Moorkens Arnold G Vulto Isabelle Huys
article_metadata: 10.1080/19420862.2020.1743517
article_metadata: MAbs
article_metadata: 2020 Jan-Dec;12(1):1743517.
article_metadata: intellectual property strategies biopharmaceutical market biosimilars monoclonal antibodies patents
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/32306833/
article_metadata: Antibodies, Monoclonal / therapeutic use Biosimilar Pharmaceuticals / therapeutic use Drug Approval / statistics & numerical data Drug Industry / statistics & numerical data
article_metadata: Antibodies, Monoclonal / therapeutic use Biosimilar Pharmaceuticals / therapeutic use Drug Approval / statistics & numerical data Drug Industry / statistics & numerical data Research Support, Non-U.S. Gov't Review Antineoplastic Agents, Immunological / therapeutic use Bevacizumab / therapeutic use Drug Approval / legislation & jurisprudence Drug Industry / economics Drug Industry / trends Europe Humans Rituximab / therapeutic use Trastuzumab / therapeutic use Antibodies, Monoclonal Antineoplastic Agents, Immunological Biosimilar Pharmaceuticals Bevacizumab Rituximab Trastuzumab
article_metadata: PMC7188399
article_metadata: 32306833
article_metadata: An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
article_metadata: 2020